Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stability of valacyclovir: implications for its oral bioavailability.

Gladys E Granero1, Gordon L Amidon

  • 1Departamento de Farmacia, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Ciudad Universitaria, 5000 Córdoba, Argentina. glagra@mail.fcq.unc.edu.ar

International Journal of Pharmaceutics
|June 9, 2006
PubMed
Summary

Valacyclovir, an acyclovir prodrug, has incomplete oral bioavailability due to premature hydrolysis. Its stability is pH-dependent, degrading faster in alkaline conditions and intestinal fluids, contributing to poor absorption.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A zinc (II) gentamicin metalloantibiotic with outstanding antimicrobial activity and reduced susceptibility to bacterial resistance mechanisms: Experimental and theoretical explorations.

Journal of inorganic biochemistry·2025
Same author

Interaction of the Antibiotic Rifampicin with Lipid Membranes.

Biomolecules·2025
Same author

A new model for ionizable drug dissolution in intestinal bicarbonate buffer.

Journal of pharmaceutical sciences·2025
Same author

Solubility vs Dissolution in Physiological Bicarbonate Buffer.

Pharmaceutical research·2024
Same author

Comparative Evaluation of Dissolution Performance in a USP 2 Setup and Alternative Stirrers and Vessel Designs: A Systematic Computational Investigation.

Molecular pharmaceutics·2024
Same author

Synergistic bactericidal combinations between gentamicin and chitosan capped ZnO nanoparticles: A promising strategy for repositioning this first-line antibiotic.

Heliyon·2024

Area of Science:

  • Pharmacokinetics and Drug Metabolism
  • Gastrointestinal Stability Studies
  • Antiviral Prodrug Research

Background:

  • Valacyclovir is an oral prodrug of acyclovir, with absolute bioavailability around 54.5%.
  • Premature hydrolysis in the gastrointestinal tract is a suspected cause of incomplete bioavailability.
  • Understanding the stability of valacyclovir is crucial for optimizing its oral delivery.

Purpose of the Study:

  • To investigate the chemical and enzymatic stability of valacyclovir.
  • To determine the influence of pH and gastrointestinal fluids on valacyclovir degradation.
  • To elucidate the relationship between valacyclovir stability and its oral bioavailability.

Main Methods:

  • Assessing valacyclovir stability in phosphate buffers across a range of pH values.

Related Experiment Videos

  • Evaluating degradation rates in simulated gastric and intestinal fluids from humans and dogs.
  • Analyzing hydrolysis kinetics, including base-catalyzed pseudo-first-order degradation.

    • Main Results:

    • Valacyclovir is chemically stable at acidic pH (<4) but degrades in alkaline conditions.
    • Degradation follows base-catalyzed pseudo-first-order kinetics in alkaline media.
    • Valacyclovir degraded more rapidly in intestinal fluids than in phosphate buffers at equivalent pH.
    • Significant degradation occurred in stomach contents, though release was minimal at pH < 4.

    Conclusions:

    • The pH-dependent stability of valacyclovir plays a critical role in its pharmacokinetic profile.
    • Accelerated degradation in the upper intestinal lumen is a significant factor contributing to the poor oral bioavailability of valacyclovir.
    • Further research into formulation strategies may be needed to mitigate intestinal degradation and improve acyclovir delivery.